arxiv: 2604.18418 · v1 · submitted 2026-04-20 · 💻 cs.CV

Recognition: unknown

MedProbeBench: Systematic Benchmarking at Deep Evidence Integration for Expert-level Medical Guideline

Jiyao Liu , Jianghan Shen , Sida Song , Tianbin Li , Xiaojia Liu , Rongbin Li , Ziyan Huang , Jiashi Lin

show 14 more authors

Junzhi Ning Changkai Ji Siqi Luo Wenjie Li Chenglong Ma Ming Hu Jing Xiong Jin Ye Bin Fu Ningsheng Xu Yirong Chen Lei Jin Hong Chen Junjun He

Authors on Pith no claims yet

Pith reviewed 2026-05-10 04:33 UTC · model grok-4.3

classification 💻 cs.CV

keywords MedProbeBenchmedical guidelinesevidence integrationLLM evaluationdeep research agentsclinical AIbenchmarkingguideline generation

0 comments

The pith

MedProbeBench shows that current AI systems fall short of expert performance in integrating evidence to develop medical guidelines.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The paper creates MedProbeBench to test AI on the full process of turning large amounts of medical evidence into clinical guidelines, using real high-quality guidelines as the target standard. Existing tests do not capture the multi-step retrieval, synthesis, and neutral judgment that guideline writing demands. Evaluation of 17 models and agents finds clear shortfalls in producing accurate, verifiable outputs. A sympathetic reader would care because medical guidelines affect real patient care, and AI assistance would only be useful if it meets those exacting standards. The new evaluation includes detailed rubrics and claim-by-claim evidence checks to make the assessment precise.

Core claim

MedProbeBench is the first benchmark that treats published clinical guidelines as expert-level references for measuring deep evidence integration. It pairs this with MedProbe-Eval, which applies more than 1,200 task-adaptive rubric criteria for overall quality and verifies precision against more than 5,130 atomic claims extracted from the guidelines. Tests across 17 LLMs and deep research agents demonstrate consistent failures in evidence selection, synthesis, and guideline generation, showing a large remaining distance to expert capability.

What carries the argument

MedProbeBench, a benchmark that uses clinical guidelines as reference targets, together with MedProbe-Eval's combination of holistic rubrics and atomic-claim evidence verification.

If this is right

AI development for medicine must improve multi-step evidence retrieval and neutral synthesis before it can support guideline-level work.
Standard question-answering or retrieval benchmarks miss the integrated judgment required for clinical guideline creation.
Using published guidelines as evaluation targets provides a scalable way to test higher-order reasoning in domain-specific settings.
Agents that maintain verifiability and neutrality across long evidence chains will be necessary for any practical medical deployment.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

The same reference-based approach could be applied to guideline development in law or policy, where authoritative documents already exist.
Progress on this benchmark would likely require advances in long-context retrieval and cross-document reasoning rather than scale alone.
Widespread use of such tests might shift AI training objectives toward verifiability and source-grounding in high-stakes domains.

Load-bearing premise

High-quality clinical guidelines with their standards of neutrality and verifiability can serve as reliable, comprehensive references for measuring AI performance in deep evidence integration.

What would settle it

A new model that produces guidelines scoring near human-expert levels on the full set of MedProbe-Eval rubrics and atomic-claim verifications, on guidelines it has never seen during training or retrieval, would indicate the reported gaps have been closed.

Figures

Figures reproduced from arXiv: 2604.18418 by Bin Fu, Changkai Ji, Chenglong Ma, Hong Chen, Jianghan Shen, Jiashi Lin, Jing Xiong, Jin Ye, Jiyao Liu, Junjun He, Junzhi Ning, Lei Jin, Ming Hu, Ningsheng Xu, Rongbin Li, Sida Song, Siqi Luo, Tianbin Li, Wenjie Li, Xiaojia Liu, Yirong Chen, Ziyan Huang.

**Figure 2.** Figure 2: Ground-truth clinical guidelines and model-generated reports are processed through an identical normalization and structuring pipeline and subsequently evaluated using a two-stage framework comprising holistic rubric-based quality assessment and fine-grained evidence verification. Together. MedProbeBench enables systematic analysis of long-horizon deep evidence integration. sesses retrieval-augmented gener… view at source ↗

**Figure 3.** Figure 3: summarizes the distribution of guidelines and atomic claims across medical domains in MedProbeBench. The benchmark spans five disease domains with a comparable number of guideline documents per domain, while exhibiting substantial variation in total claim counts and average claims per guideline, reflecting differences in guideline length and structural complexity across specialties. Across all tasks, Med… view at source ↗

**Figure 4.** Figure 4: reveals significant performance variation across knowledge types. Systems achieve the highest accuracy Claude Sonnet 4 Claude Sonnet 4 (T) Gemini 3 Flash Gemini 3 Flash (T) GPT-4.1 GPT-5 GPT-5.2 Grok-4 Baichuan-M2-Plus Baichuan-M3-Plus LLM + Search Tools 33.8 37.1 30.3 28.4 24.6 20.2 15.6 34.4 34.5 28.0 27.5 23.7 17.6 13.5 36.4 34.4 28.6 20.7 24.1 14.6 12.5 32.7 33.2 26.1 21.4 22.8 15.0 13.5 33.5 33.2 26.4… view at source ↗

**Figure 5.** Figure 5: Coverage vs. Consistency by guideline section type. Each point represents one section type; color encodes coverage level. The pronounced horizontal spread against a narrow vertical range reveals that citation consistency remains uniformly high while claim coverage varies dramatically across sections, exposing a structural gap between surface fluency and substantive evidence grounding. racy on clinical clai… view at source ↗

**Figure 6.** Figure 6: Human and GPT-4.1 evaluation scores for higherperforming Good systems and lower-performing Bad systems across four dimensions and the overall score. Holistic Rubrics Alignment [PITH_FULL_IMAGE:figures/full_fig_p009_6.png] view at source ↗

read the original abstract

Recent advances in deep research systems enable large language models to retrieve, synthesize, and reason over large-scale external knowledge. In medicine, developing clinical guidelines critically depends on such deep evidence integration. However, existing benchmarks fail to evaluate this capability in realistic workflows requiring multi-step evidence integration and expert-level judgment. To address this gap, we introduce MedProbeBench, the first benchmark leveraging high-quality clinical guidelines as expert-level references. Medical guidelines, with their rigorous standards in neutrality and verifiability, represent the pinnacle of medical expertise and pose substantial challenges for deep research agents. For evaluation, we propose MedProbe-Eval, a comprehensive evaluation framework featuring: (1) Holistic Rubrics with 1,200+ task-adaptive rubric criteria for comprehensive quality assessment, and (2) Fine-grained Evidence Verification for rigorous validation of evidence precision, grounded in 5,130+ atomic claims. Evaluation of 17 LLMs and deep research agents reveals critical gaps in evidence integration and guideline generation, underscoring the substantial distance between current capabilities and expert-level clinical guideline development. Project: https://github.com/uni-medical/MedProbeBench

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Desk Editor's Note private letter to a colleague

MedProbeBench sets up a benchmark for LLM evidence synthesis in medicine by using published guidelines as the target, but the construction of its rubrics and claims leaves open questions about what the scores actually capture.

read the letter

The paper introduces MedProbeBench to test deep evidence integration for generating clinical guidelines, evaluating 17 models and agents against real published guidelines with a framework of rubrics and atomic claims. It reports clear performance shortfalls in multi-step reasoning and evidence handling. That is the core new piece: a domain-specific benchmark that moves beyond generic QA or retrieval tests toward the kind of workflow experts actually use when building guidelines. The authors deserve credit for grounding the tasks in existing high-quality guidelines rather than inventing synthetic cases, which makes the failures more relevant to real medical AI use cases. The split into holistic quality rubrics and fine-grained evidence verification is a reasonable attempt to make scoring more transparent than single overall scores. The reported gaps are useful signals for anyone building retrieval-augmented systems for healthcare. The main soft spot is the lack of visible detail on how the 1,200 rubric criteria and 5,130 atomic claims were derived and checked. If those were extracted directly from guideline text without separate tracing to primary trial data or cross-guideline consistency checks, then the benchmark risks rewarding models that reproduce panel consensus rather than demonstrating independent evidence synthesis. Guidelines routinely include value judgments and updates over time, so treating them as unambiguous ground truth needs explicit justification. No inter-rater reliability numbers or expert validation steps are mentioned in the available description, which makes it hard to gauge how stable the scores would be. This paper is aimed at researchers working on medical AI evaluation and deep research agents. Readers who care about benchmark design in high-stakes domains will find the task framing and the reported model weaknesses worth looking at. It is solid enough to deserve peer review, mainly because the underlying problem is real and the proposed setup is a step forward even if the current execution needs more documentation on rubric provenance. I would send it to referees and ask specifically for the construction protocol and any steps taken to reduce circularity.

Referee Report

2 major / 2 minor

Summary. The manuscript introduces MedProbeBench, the first benchmark that uses published high-quality clinical guidelines as expert-level references to evaluate LLMs and deep research agents on deep evidence integration and multi-step reasoning for guideline generation. It proposes the MedProbe-Eval framework consisting of holistic rubrics with 1,200+ task-adaptive criteria and fine-grained evidence verification grounded in 5,130+ atomic claims, then reports results from 17 models that indicate substantial gaps relative to expert performance.

Significance. If the rubrics and atomic claims are shown to be robustly derived and validated, the benchmark would provide a valuable, realistic testbed for measuring progress in complex medical evidence synthesis, an area where current systems fall short. The scale of the evaluation and focus on neutrality/verifiability standards from real guidelines are strengths that could help prioritize research on retrieval, multi-hop reasoning, and judgment in healthcare AI.

major comments (2)

[Abstract / MedProbe-Eval framework] Abstract and MedProbe-Eval description: the claim that the 1,200+ rubric criteria and 5,130+ atomic claims enable 'rigorous validation of evidence precision' and 'comprehensive quality assessment' is load-bearing for the central finding of 'critical gaps,' yet the manuscript provides no details on derivation from primary evidence sources, validation against expert judgment, or inter-rater reliability metrics. Without this, measured deficiencies may reflect rubric construction artifacts rather than model limitations in evidence integration.
[MedProbeBench construction] Benchmark construction: treating published guidelines as unambiguous expert targets for 'expert-level' performance assumes they represent pure evidence synthesis, but guidelines routinely embed panel value judgments, conflict resolutions, and temporal updates. The manuscript does not clarify whether the atomic claims carry direct provenance to primary trial data or are back-translated from guideline text; this directly affects whether 'gaps' measure retrieval/reasoning failures or divergence from consensus.

minor comments (2)

[Abstract] The GitHub repository link is given but the manuscript does not specify dataset release format, licensing, or exact number of source guidelines used, which would aid reproducibility.
[Evaluation framework] Notation for rubric criteria and atomic claims is introduced without a clear example table showing one full rubric and its linked claims, making it hard to assess granularity.

Simulated Author's Rebuttal

2 responses · 0 unresolved

We thank the referee for their constructive and detailed feedback on MedProbeBench. The comments identify important areas for improving transparency in the benchmark's construction and evaluation framework. We address each major comment below and outline planned revisions to the manuscript.

read point-by-point responses

Referee: [Abstract / MedProbe-Eval framework] Abstract and MedProbe-Eval description: the claim that the 1,200+ rubric criteria and 5,130+ atomic claims enable 'rigorous validation of evidence precision' and 'comprehensive quality assessment' is load-bearing for the central finding of 'critical gaps,' yet the manuscript provides no details on derivation from primary evidence sources, validation against expert judgment, or inter-rater reliability metrics. Without this, measured deficiencies may reflect rubric construction artifacts rather than model limitations in evidence integration.

Authors: We agree that the current manuscript lacks sufficient detail on the derivation, validation, and reliability of the rubric criteria and atomic claims, which is necessary to fully support claims of rigorous evaluation. The rubrics were constructed iteratively by medical domain experts drawing directly from the structural and evidentiary standards in the source guidelines, while atomic claims were extracted sentence-by-sentence from guideline text with explicit mapping to cited primary studies. To address the referee's concern, we will add a dedicated subsection in the Methods (and supporting appendix) describing the full derivation pipeline, the expert review process used for validation, and inter-rater agreement statistics from the construction phase. This revision will allow readers to evaluate whether observed gaps reflect model limitations or potential artifacts in the evaluation criteria. revision: yes
Referee: [MedProbeBench construction] Benchmark construction: treating published guidelines as unambiguous expert targets for 'expert-level' performance assumes they represent pure evidence synthesis, but guidelines routinely embed panel value judgments, conflict resolutions, and temporal updates. The manuscript does not clarify whether the atomic claims carry direct provenance to primary trial data or are back-translated from guideline text; this directly affects whether 'gaps' measure retrieval/reasoning failures or divergence from consensus.

Authors: We acknowledge that clinical guidelines incorporate consensus elements, value judgments, and periodic updates in addition to evidence synthesis, and that this nuance affects interpretation of model performance. Our benchmark intentionally uses published guidelines as the reference standard precisely because they represent the current expert consensus on evidence integration and clinical recommendation. The atomic claims are extracted from the guideline text but preserve direct provenance links to the primary sources cited in the guideline (e.g., specific RCTs or systematic reviews). We will revise the manuscript to explicitly describe this extraction process, provide illustrative examples of claim provenance, and clarify that the evaluation measures fidelity to the guideline's integrated evidence synthesis rather than independent re-derivation of consensus from raw trials. revision: yes

Circularity Check

0 steps flagged

No circularity: benchmark uses external guidelines as independent ground truth

full rationale

The paper constructs MedProbeBench by extracting 5,130+ atomic claims and 1,200+ rubric criteria directly from published clinical guidelines, which function as external references rather than outputs derived from the 17 evaluated LLMs or deep research agents. No parameters are fitted to model performance, no self-citations underpin the core evaluation framework, and no equations or ansatzes reduce the measured gaps to the benchmark inputs by construction. The derivation remains self-contained against these external sources.

Axiom & Free-Parameter Ledger

0 free parameters · 2 axioms · 0 invented entities

The central claim rests on the assumption that clinical guidelines embody expert-level evidence integration standards and that the custom rubrics plus atomic claim verification provide a valid measurement of AI performance; no free parameters or invented physical entities are introduced.

axioms (2)

domain assumption Clinical guidelines represent the pinnacle of medical expertise due to their rigorous standards in neutrality and verifiability.
Invoked in the abstract to justify using guidelines as references for evaluation.
ad hoc to paper The proposed holistic rubrics and fine-grained evidence verification accurately capture quality and precision in guideline generation.
Central to the MedProbe-Eval framework described in the abstract.

pith-pipeline@v0.9.0 · 5574 in / 1376 out tokens · 42079 ms · 2026-05-10T04:33:48.056100+00:00 · methodology

discussion (0)

Reference graph

Works this paper leans on

28 extracted references

[1]

GT = 10 by definition - do NOT independently judge quality
[2]

Score ONLY the distance between GENERATED and REFERENCE
[3]

Any missing, weaker, or less specific content MUST reduce the score
[4]

Vagueness counts as deviation when the reference is specific or evidence-based
[5]

Equal section titles do NOT imply equivalence - content depth and precision matter
[6]

scores": [ {

When uncertain, subtract points - never inflate scores in benchmark settings ## Output Requirements (STRICT): - Output ONLY a valid JSON object - No explanations, no markdown, no additional text - Use EXACTLY the following structure: {"scores": [ {"criterion": "<criterion name>", "score": <integer 0-10>, "reason": "<explicit difference from GT explaining ...
[7]

One fact per claim: split compound sentences into atomic units
[8]

Preserve details: retain all quantitative values, percentages, and ranges
[9]

SMARCB1 (also known as hSNF5, INI1, or BAF47)

Preserve aliases: e.g., "SMARCB1 (also known as hSNF5, INI1, or BAF47)"
[10]

see Figure 1

Omit figure and table cross-references (e.g., "see Figure 1")
[11]

is_hit": true/false,

Do not paraphrase: keep the original medical terminology A.2.3. TASKSUCCESSRATE This prompt determines whether a gold-standard (GT) claim is semantically covered by any predicted claim. Determine if the GT claim is semantically covered by any predicted claim. GT Claim: {gt_claim} Predicted Claims: {pred_claims_json} Match if: same medical fact, equivalent...
[12]

Author et al. Title. *Journal*. Year;Volume:Pages. URL: https://pubmed.ncbi.nlm.nih.gov /XXXXXXXX/
[13]

Author et al. Title. *Journal*. Year;Volume:Pages. URL: https://doi.org/10.XXXX/XXXXX ...(List all cited references) C. Evaluation Reliability Due to the high computational cost of deep research evaluation, each system is evaluated once per task. Result reliability is supported by three factors: (1) each system’s score aggregates over approximately 5,130 ...

2025
[14]

Atypical spindle cell lipomatous tumor: clinicopathologic characterization of 232 cases demonstrating a morphologic spectrum.Am J Surg Pathol.2017;41(2):234–44

Mariño-Enriquez A, Nascimento AF, Ligon AH, et al. Atypical spindle cell lipomatous tumor: clinicopathologic characterization of 232 cases demonstrating a morphologic spectrum.Am J Surg Pathol.2017;41(2):234–44. PMID:27879515

2017
[15]

Atypical

Creytens D, Mentzel T, Ferdinande L, et al. “Atypical” pleomorphic lipomatous tumor: a clinicopathologic, immunohistochemical and molecular study of 21 cases, emphasizing its relationship to atypical spindle cell lipomatous tumor and suggesting a morphologic spectrum.Am J Surg Pathol.2017;41(11):1443–55. PMID:28877053

2017
[16]

Atypical spindle cell/pleomorphic lipomatous tumor: a clinicopathologic, immunohistochemical, and molecular study of 20 cases.Pathol Int.2018;68(10):550–6

Bahadır B, Behzato˘glu K, Hacıhasano˘glu E, et al. Atypical spindle cell/pleomorphic lipomatous tumor: a clinicopathologic, immunohistochemical, and molecular study of 20 cases.Pathol Int.2018;68(10):550–6. PMID:30198097

2018
[17]

Creytens D, van Gorp J, Savola S, et al. Atypical spindle cell lipoma: a clinicopathologic, immunohistochemical, and molecular study emphasizing its relationship to classical spindle cell lipoma.Virchows Arch.2014;465(1):97–108. PMID:24659226

2014
[18]

Atypical spindle cell lipomatous tumor with benign heterologous (metaplastic) cartilaginous differentiation.Int J Surg Pathol.2019;27(5):521–3

Creytens D, Ferdinande L, van Gorp J, et al. Atypical spindle cell lipomatous tumor with benign heterologous (metaplastic) cartilaginous differentiation.Int J Surg Pathol.2019;27(5):521–3. PMID:3070805

2019
[19]

Mentzel T, Palmedo G, Kuhnen C. Well-differentiated spindle cell liposarcoma (‘atypical spindle cell lipomatous tumor’) does not belong to the spectrum of atypical lipomatous tumor but has a close relationship to spindle cell lipoma: clinicopathologic, immunohistochemical, and molecular analysis of six cases.Mod Pathol.2010;23(5):729–36. PMID:20228779

2010
[20]

Monosomy 7 and absence of 12q amplification in two cases of spindle cell liposarcomas.Cancer Genet Cytogenet.2008;184(2):99–104

Italiano A, Chamboissiere M, Attias R, et al. Monosomy 7 and absence of 12q amplification in two cases of spindle cell liposarcomas.Cancer Genet Cytogenet.2008;184(2):99–104. PMID:18617058

2008
[21]

fat-only

Agaimy A. Anisometric cell lipoma: insight from a case series and review of the literature on adipocytic neoplasms in survivors of retinoblastoma suggest a role for RB1 loss and possible relationship to fat-predominant (“fat-only”) spindle cell lipoma.Ann Diagn Pathol.2017;29:52–6. PMID:28807343

2017
[22]

Fat-rich

Creytens D, Mentzel T, Ferdinande L, et al. “Fat-rich” (spindle cell-poor) variants of atypical spindle cell lipomatous tumor show similar morphologic, immunohistochemical and molecular features as “dysplastic lipomas”: Are they related lesions?Am J Surg Pathol.2019;43(2):288–9. PMID:30211727

2019
[23]

Atypical mitoses are present in otherwise classical pleomorphic lipomas—reply

Creytens D, Mentzel T, Ferdinande L, et al. Atypical mitoses are present in otherwise classical pleomorphic lipomas—reply. Hum Pathol.2018;81:300–2. PMID:30084357

2018
[24]

Atypical multivacuolated lipoblasts and atypical mitoses are not compatible with the diagnosis of spindle cell/pleomorphic lipoma.Hum Pathol.2018;74:188–9

Creytens D, Mentzel T, Ferdinande L, et al. Atypical multivacuolated lipoblasts and atypical mitoses are not compatible with the diagnosis of spindle cell/pleomorphic lipoma.Hum Pathol.2018;74:188–9. PMID:29317234

2018
[25]

A contemporary review of myxoid adipocytic tumors.Semin Diagn Pathol.2019;36(2):129–41

Creytens D. A contemporary review of myxoid adipocytic tumors.Semin Diagn Pathol.2019;36(2):129–41. PMID:30853315

2019
[26]

Deyrup AT, Chibon F, Guillou L, et al. Fibrosarcoma-like lipomatous neoplasm: a reappraisal of so-called spindle cell liposar- coma, defining a unique lipomatous tumor unrelated to other liposarcomas.Am J Surg Pathol.2003;27(9):1373–8. PMID:23887155

2003
[27]

Tumours composed of fat are no longer a simple diagnosis: an overview of fatty tumours with a spindle cell component.J Clin Pathol.2018;71(6):483–92

McCarthy AJ, Chetty R. Tumours composed of fat are no longer a simple diagnosis: an overview of fatty tumours with a spindle cell component.J Clin Pathol.2018;71(6):483–92. PMID:29358476

2018
[28]

ASPLT lacks MDM2 and CDK4 amplification

Yong M, Raza AS, Greaves TS, et al. Fine-needle aspiration of a pleomorphic lipoma of the head and neck: a case report.Diagn Cytopathol.2005;32(2):110–3. PMID:15637670 G.3. Step 1 — Claim Decomposition Each guideline (GT and prediction) is first decomposed into atomic, independently verifiable claims using the prompt in Appendix A.2.2. Table 12 shows a re...

2005